Oxford vaccine shows 90% efficacy in Phase-3 trial
Two doses of the vaccine given in two different regimen showed different efficacies. In the case of the regimen (involving
Read MoreTwo doses of the vaccine given in two different regimen showed different efficacies. In the case of the regimen (involving
Read MoreOffering the vaccine right away to those in the placebo group will first require unblinding the study. Unblinding the study and offering the vaccine to the placebo group will make it almost impossible to gather further information on vaccine efficacy, thus making full licensure challenging.
Read MoreThe results were published online in The Lancet on November 19. The results are based on the study of 560
Read MoreOn November 18, Pfizer announced that the final efficacy analysis of its candidate mRNA-based vaccine (BNT162b2) in phase-3 trial has
Read MoreThe interim results of Moderna’s mRNA vaccine show that the vaccine has 94.5% efficacy in preventing COVID-19. The interim analysis,
Read MoreThe results of the Phase-1 trial, announced in August, first through a press release and then through a preprint a
Read MoreThe companies have come together under the umbrella of the non-profit Medicines Patent Pool (MPP). Indian companies that have pledged
Read MoreThe government recently said it will procure the vaccine and distribute it under a special COVID-19 immunisation programme to certain
Read MoreSo far, six countries — Denmark, the Netherlands, Spain, Sweden, Italy and the U.S. — have reported SARS-CoV-2 in farmed
Read More